Wall Street analyst estimates for Marsh & McLennan Companies, Inc. (MRSH): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands.
Consensus price target
$205.43 (+1 % vs price $203.63)
between $182.00 and $234.00 · 6 targets published in the last quarter
Closing price, Nov 3
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $28.8B | $28.5B – $28.9B | $10.49 | 14 |
| 2027E | $30.2B | $29.6B – $30.9B | $11.46 | 14 |
| 2028E | $31.8B | $30.7B – $32.8B | $12.59 | 6 |
Figures in USD · consensus as of November 2, 2026
Analyst Consensus
| Strong Buy | 1 |
| Buy | 10 |
| Hold | 22 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 34 |
| Avg rating (−2 sell to +2 buy) | 0.32 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2027-01-28 | $2.20 | ||
| 2026-10-15 | $2.03 | $1.97 | +3.0% |
| 2026-07-21 | $2.96 | $2.90 | +2.1% |
| 2026-04-16 | $3.29 | $3.22 | +2.2% |
| 2026-01-29 | $2.12 | $1.97 | +7.6% |
| 2025-10-16 | $1.85 | $1.78 | +3.9% |
| 2025-07-17 | $2.72 | $2.67 | +1.9% |
| 2025-04-17 | $3.06 | $3.02 | +1.3% |
Valuation Ratios
| P/E Ratio | 24.36 |
| Price / Book | 6.60 |
| Dividend Yield | 1.86% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.21B | $14.02B | $14.95B | $16.65B | $17.22B | $19.82B | $20.72B | $22.74B | $24.46B | $26.98B |
| Cost of Revenue | $7.69B | $8.09B | $8.61B | $9.73B | $10.13B | $11.43B | $12.07B | $13.10B | $14.00B | $15.58B |
| Gross Profit | $5.52B | $5.94B | $6.34B | $6.92B | $7.09B | $8.39B | $8.65B | $9.64B | $10.46B | $11.40B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $7.69B | $8.09B | $8.61B | $9.73B | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | $3.09B | $3.28B | $3.58B | $4.24B | $4.03B | $4.08B | $4.37B | $4.36B | $4.64B | $5.18B |
| Operating Income | $2.43B | $2.65B | $2.76B | $2.68B | $3.07B | $4.31B | $4.28B | $5.28B | $5.82B | $6.22B |
| EBITDA | $3.11B | $3.36B | $3.03B | $3.61B | $4.05B | $5.40B | $5.27B | $6.32B | $6.93B | $7.39B |
| Interest Expense | $189.0M | $237.0M | $290.0M | $524.0M | $515.0M | $444.0M | $469.0M | $578.0M | $700.0M | $960.0M |
| Pre-tax Income | $2.48B | $2.64B | $2.24B | $2.44B | $2.79B | $4.21B | $4.08B | $5.03B | $5.48B | $5.54B |
| Income Tax | $685.0M | $1.13B | $574.0M | $666.0M | $747.0M | $1.03B | $995.0M | $1.22B | $1.36B | $1.30B |
| Net Income | $1.77B | $1.49B | $1.65B | $1.74B | $2.02B | $3.14B | $3.05B | $3.76B | $4.06B | $4.16B |
| EPS | $3.41 | $2.91 | $3.26 | $3.44 | $3.98 | $6.20 | $6.11 | $7.60 | $8.25 | $8.48 |
| EPS (Diluted) | $3.37 | $2.87 | $3.23 | $3.41 | $3.94 | $6.13 | $6.04 | $7.53 | $8.18 | $8.43 |
| Shares Outstanding (Diluted) | 524.0 M | 519.0 M | 511.0 M | 511.0 M | 512.0 M | 513.0 M | 505.0 M | 499.0 M | 496.0 M | 490.0 M |
Price
| Price | $203.63 (closing price, November 3, 2026) |
| Market Cap | $97.2B |
| Exchange | NYSE |
| Country | US |
Related companies: WTW · AON · AJG · BRO · RYAN
Explore sector: Financial Services · Insurance - Brokers
More sections of MRSH: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks